Kayoko Hayakawa

6PUBLICATIONS
21CO-AUTHORS
Major global burdens of diseaseMedical infection agents (incl. prions)Environmental biotechnology diagnostics (incl. biosensors)Cardiology (incl. cardiovascular diseases)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 27, 2026
Difficult-to-treat resistance (DTR), treatment, and outcomes of carbapenem-resistant Enterobacterales infections in the setting of IMP-type carbapenemase predominance in Japan.

|Jun 06, 2024
Clinical characteristics and genome epidemiology of Stenotrophomonas maltophilia in Japan.

Ryota Hase, Aki Sakurai, Masahiro Suzuki

|Sep 13, 2023
Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.

Kayoko Hayakawa, Yasufumi Matsumura, Kohei Uemura

|Sep 28, 2020
Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan.

Nobuaki Matsunaga, Kayoko Hayakawa, Mari Terada

|Oct 30, 2019
Eight-Year Experience of Antimicrobial Stewardship Program and the Trend of Carbapenem Use at a Tertiary Acute-Care Hospital in Japan-The Impact of Postprescription Review and Feedback.

Tsubasa Akazawa, Yoshiki Kusama, Haruhisa Fukuda

|Jul 26, 2017
Impact of rapid identification of positive blood cultures using the Verigene system on antibiotic prescriptions: A prospective study of community-onset bacteremia in a tertiary hospital in Japan.

Kayoko Hayakawa, Kazuhisa Mezaki, Masao Kobayakawa

Pageof 1

Frequent Collaborators

3 joint publications

Norio Ohmagari

3 joint publications

Yasufumi Matsumura

2 joint publications

Ryota Hase

2 joint publications

Naoya Itoh